SCHEMBL5484893

SCHEMBL5484893

CC(C)(Cc1c[nH]c2c(OCc3ccccc3)cccc12)NC(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.57
PLA2G2A P14555 1/20 0.57
TRPM8 Q7Z2W7 1/20 0.57
ADRB3 P13945 4/20 0.48
ADRB2 P07550 2/20 0.42
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
ADRB1 P08588 1/20 0.41
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
TACR1 P25103 2/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
MGLL Q99685 1/20 0.41
BRD4 O60885 1/20 0.40
CYP2D6 P10635 1/20 0.40
SGMS2 Q8NHU3 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5645027 0.91 LTA4H (0.54) LTA4HPLA2G2ATRPM8ADRB3ADRB2
SCHEMBL5859930 0.82 LTA4H (0.65) LTA4HPLA2G2ATRPM8ADRB3ADRB2
SCHEMBL5859925 0.82 LTA4H (0.65) LTA4HPLA2G2ATRPM8ADRB3ADRB2
SCHEMBL5485080 0.82 LTA4H (0.67) LTA4HPLA2G2ATRPM8ADRB3ADRB2
SCHEMBL5482928 0.79 ADRB3 (0.60) LTA4HPLA2G2ATRPM8ADRB3ADRB2
SCHEMBL5646073 0.79 LTA4H (0.58) LTA4HPLA2G2ATRPM8ADRB3ADRB2
SCHEMBL5480068 0.79 LTA4H (0.67) LTA4HPLA2G2ATRPM8ADRB3ADRB2
SCHEMBL5644205 0.77 ADRB3 (0.47) LTA4HPLA2G2ATRPM8ADRB3ADRB2
SCHEMBL837541 0.77 LTA4H (0.65) LTA4HPLA2G2ATRPM8ADRB3ADRB2
SCHEMBL837542 0.77 LTA4H (0.65) LTA4HPLA2G2ATRPM8ADRB3ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7217724-B2 Indole, indazole, and benzazole derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-05-15 US disclosed
US-20060063762-A1 Indole indazole and benzazole derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2006-03-23 US disclosed
EP-1514869-A1 INDOLE, INDAZOLE, AND BENZAZOLE DERIVATIVE SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-03-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063762-A1 Indole indazole and benzazole derivative ADRB3, ADRA2C, ADRB2 LTA4H 3017/4885PLA2G2A 3711/4885TRPM8 1529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.